NFE2L2 and diabetes mellitus: Opposing this, pharmacological or transgenic activation of Nrf2 in experimental DM attenuated retinopathy, nephropathy, neuropathy, atherosclerosis, and liver damage by suppressing oxidative stress, inflammation, and apoptosis and independent of modulating hyperglycemia [10,11,17,18,19].